Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    18381905 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Trial of DMXB-A in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: 3-2,4 dimethoxybenzylidene 75 or 150 mg bid;   Drug: Placebo
2 Not yet recruiting Phase I Nicotinic Agonist Treatment Trial for Autism
Condition: Autism
Interventions: Drug: DMXB-A 150 mg;   Other: placebo;   Drug: DMXB-A 75 mg
3 Recruiting Nicotinic Receptors and Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: DMXB-A-SR;   Other: Placebo

Indicates status has not been verified in more than two years